Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
Background and Aims. The impact of COVID-19 has been of great concern in patients with inflammatory bowel disease (IBD) worldwide, including an increased risk of severe outcomes and/or possible flare of IBD. This study aims to evaluate prevalence, outcomes, the impact of COVID-19 in patients with IB...
Saved in:
Main Authors: | Panu Wetwittayakhlang, Farah Albader, Petra A Golovics, Gustavo Drügg Hahn, Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Peter L Lakatos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2021/7591141 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
by: Amine Benmassaoud, et al.
Published: (2016-01-01) -
Course of COVID-19 in Patients with Inflammatory Bowel Disease: Regional Experience
by: L. M. Kupkenova, et al.
Published: (2023-02-01) -
Corrigendum to “Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease”
by: Katalin Eszter Müller, et al.
Published: (2015-01-01) -
Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in Canada
by: Geoffrey C Nguyen, et al.
Published: (2014-01-01) -
Strongyloides Colitis as a Harmful Mimicker of Inflammatory Bowel Disease
by: Julio Poveda, et al.
Published: (2017-01-01)